Geode Capital Management’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6M | Buy |
|
|||||
|
2025
Q1 | $2.8M | Buy |
|
|||||
|
2024
Q4 | $3.23M | Buy |
|
|||||
|
2024
Q3 | $1.42M | Buy |
|
|||||
|
2024
Q2 | $1.03M | Buy |
|
|||||
|
2024
Q1 | $1.16M | Buy |
|
|||||
|
2023
Q4 | $828K | Hold |
|
|||||
|
2023
Q3 | $928K | Sell |
|
|||||
|
2023
Q2 | $1.28M | Buy |
|
|||||
|
2023
Q1 | $1.22M | Buy |
|
|||||
|
2022
Q4 | $530K | Buy |
|
|||||
|
2022
Q3 | $718K | Buy |
|
|||||
|
2022
Q2 | $675K | Buy |
|
|||||
|
2022
Q1 | $1.25M | Buy |
|
|||||
|
2021
Q4 | $1.73M | Buy |
|
|||||
|
2021
Q3 | $1.18M | Buy |
|
|||||
|
2021
Q2 | $535K | Buy |
|
|||||
|
2021
Q1 | $268K | Buy |
|
|||||
|
2020
Q4 | $188K | Buy |
|
|||||
|
2020
Q3 | $148K | Hold |
|
|||||
|
2020
Q2 | $204K | Buy |
|
|||||
|
2020
Q1 | $36K | Hold |
|
|||||
|
2019
Q4 | $54K | Hold |
|
|||||
|
2019
Q3 | $45K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $58K | Hold |
|
|||||
|
2018
Q4 | $52K | Hold |
|
|||||
|
2018
Q3 | $86K | Hold |
|
|||||
|
2018
Q2 | $96K | Hold |
|
|||||
|
2018
Q1 | $280K | Hold |
|
|||||
|
2017
Q4 | $371K | Sell |
|
|||||
|
2017
Q3 | $549K | Hold |
|
|||||
|
2017
Q2 | $375K | Sell |
|
|||||
|
2017
Q1 | $392K | Buy |
|
|||||
|
2016
Q4 | $240K | Buy |
|
|||||
|
2016
Q3 | $354K | Buy |
|
|||||
|
2016
Q2 | $116K | Sell |
|
|||||
|
2016
Q1 | $184 | Sell |
|
|||||
|
2015
Q4 | $462K | Buy |
|
|||||
|
2015
Q3 | $450K | Buy |
|